ftInvstr
PGHL · Healthcare ₹5697.5 -0.33% Mkt Cap ₹9442 Cr overvalued

PGHL

Healthcare Drug Manufacturers - Specialty & Generic
₹5697.5
-0.33% today · 30d +8.81%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for PGHL. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹382 Cr
+17.72% YoY
NET PROFIT
₹112 Cr
+25.94% YoY
OPM
40.44%
+2.48pp YoY
EPS
₹67.18
PE 27.56
Intrinsic value · DCF ₹960.85 · Margin of safety -83.1% (overvalued) · FCF yield 3.41%
◇ Sector Position
PEERPEROCE %
PGHL27.56—
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
72
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation REASONABLE 60
Growth STRONG 80
Profitability HIGH 100
Technicals NEUTRAL 65
Risk LOW 90
Key Stats
TTM PE
27.56
P/B
14.57
52W HIGH
₹6975.0
OFF HIGH
-18.32%
DIV YIELD
2.72%
MKT CAP
₹9442 Cr
◉ Active Signals
MACDBullish42.5267
RSI(14)Neutral57.09
Street Consensus
1 analyst
₹7090.0
mean target
Low ₹7090.0Now ₹5697.5High ₹7090.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold PGHL and at what entry.

Sign up freeSign in